Leaderboard

En | De
Sie sind hier: Hämatologie » Neoplasie 25. Februar 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Anämie
Gerinnungsstörungen
Neoplasie
Anderes
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8309  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 166164  
   
Exploring potential biomarkers of diffuse large B-cell lymphoma through multi-dimensional data.
Clin Transl Oncol
Li C, Han X, Hu X, Du S, An P, Wang D.
PMID: 41739400 [PubMed - as supplied by publisher]


Superiority of high-dose cytarabine-based mobilisation over cyclophosphamide or plerixafor in primary CNS lymphoma.
Ann Hematol
Li Q, Zhu L, Ma Y, Ma J, Zhang M, Lin Z, Chen B.
PMID: 41739202 [PubMed - indexed for MEDLINE]


Allogeneic Hematopoietic Stem Cell Transplantation for Children With Mixed Phenotype Acute Leukemia: A Single-Center Retrospective Study.
J Pediatr Hematol Oncol
Yang W, Qin M, Jia C, Zhu G, Yang J, Zheng J, Wang B.
PMID: 41738872 [PubMed - indexed for MEDLINE]


Combined Tyrosine Kinase Inhibitors and Chemotherapy Based on Minimal Residual Disease in Children With Ph(+) Acute Lymphoblastic Leukemia: A Phase 2 Single-Arm Trial, JCCG ALL-Ph13.
Pediatr Blood Cancer
Sato A, Kodama Y, Kawasaki H, Ohki K, Oshima K, Deguchi T, Hashii Y, Iijima-Yamashita Y, Yonezawa S, Imamura CK, Shima H, Sakaguchi H, Kato K, Kato M, Hiramatsu H, Ito E, Yamamoto M, Inoue A, Sakaguchi K, Kosaka Y, Hasegawa D, Kiyokawa N, Kada A, Saito AM, Manabe A, Horibe K, Shimada H.
PMID: 41738671 [PubMed - indexed for MEDLINE]


Model-Based Strategy for 6-Mercaptopurine Treatment in Acute Lymphoblastic Leukemia Maintenance Phase: Prediction of 6-TGN and 6-MMP Concentrations to Optimize Treatment.
Pediatr Blood Cancer
Ravix A, Maillat A, Choong E, Csajka C, Guidi M, Ceppi F.
PMID: 41738669 [PubMed - indexed for MEDLINE]


[Primary mediastinal B-cell lymphoma presenting as cardiac tamponade: the importance of a multimodality imaging approach].
G Ital Cardiol (Rome)
Maffè S, Paffoni P, Bergamasco L, Arrondini M, Prenna E, Leva L, Ariotti S, Facchini E, Paino AM, Ticozzi S, Dellavesa P.
PMID: 41738407 [PubMed - indexed for MEDLINE]


Diazinon may increase the risk of acute lymphoblastic leukemia by inducing MGMT promoter methylation.
Environ Epigenet
Rafeeinia A, Darabi MK, Sadeghi R, Bazyar H, Saeed F, Dianati M.
PMID: 41736802 [PubMed]


EXPRESS: The Impact of CD25/CD200 Different Expression Patterns on Acute Myeloid Leukemia Patients.
J Investig Med
Abou Koura RG, Amer RS, Allam AA, Elkholy RA.
PMID: 41736570 [PubMed - as supplied by publisher]


Acalabrutinib in Chronic Lymphocytic Leukemia: Pharmacology and Emerging Clinical Perspectives.
Eur J Haematol
Gaidano G, Danesi R.
PMID: 41736301 [PubMed - as supplied by publisher]


Predictive value of MRD monitoring by BCR clonality in the ZUMA-7 randomized clinical trial for CAR T therapy in r/r lymphoma.
Br J Haematol
Miles B, Mao D, Vardhanabhuti S, Bedognetti D, Filosto S, Shen R.
PMID: 41735224 [PubMed - as supplied by publisher]


Retrospective Cohort Analysis of Treatment Patterns, Survival, and Cost-Effectiveness in Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Lower Austria (2018-2022).
Cancer Med
Singer J, Gottsauner-Wolf S, Behrens DA.
PMID: 41735029 [PubMed - indexed for MEDLINE]


Patient-centered communication during diagnostic conversations in relation to parental psychosocial outcomes: An exploratory observational study in pediatric leukemia.
Patient Educ Couns
Buursma P, Mostert A, van den Bergh EMM, Dors N, Kars MC, Hoogerbrugge PM, Grootenhuis MA, Schepers SA.
PMID: 41734428 [PubMed - as supplied by publisher]


No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse.
Blood Adv
Murdock HM, Kim HT, Maurer K, Kelkar A, Shapiro RM, Gooptu M, Romee R, Nageshwar PK, Garrity HM, Shimony S, Luskin MR, Winer ES, Vedula RS, Stahl M, Chen EC, Volpe V, Garcia JS, Wadleigh M, DeAngelo DJ, Stone RM, Wu CJ, Cutler CS, Koreth J, Ritz J, Antin JH, Ho VT, Nikiforow S, Soiffer RJ.
PMID: 41733975 [PubMed - indexed for MEDLINE]


Predictive capacity of peritransplant measurable residual disease thresholds in NPM1-mutant acute myeloid leukemia.
Blood Adv
Schroeder JC, Schwartz F, Metzdorf J, Barensteiner N, Mix L, Necke LM, Fehn A, Riedel A, Jentzsch L, Faustmann P, Vogel W, Bethge WA, Schroeder T, Lengerke C.
PMID: 41733971 [PubMed - indexed for MEDLINE]


MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphoma.
Blood Adv
Ruan J, Bond DA, Shah B, Allan JN, Rutherford SC, Gribbin C, Chen Z, Bhinder B, Tam W, Rossi D, Xiang J, Hobbie B, Harbhajan M, Sahni TK, Chen GZ, Sigouros M, Inghirami G, Chen-Kiang S, Elemento O, Maddocks K, Leonard JP, Martin P.
PMID: 41733969 [PubMed - indexed for MEDLINE]


Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphoma.
Blood Adv
Darnell EP, Gallagher KME, Kanska J, Scarfò I, Balderrama-Gutierrez G, Berger TR, Budka J, Bozym DJ, Huang T, Shen R, Leick MB, Maus MV.
PMID: 41733967 [PubMed - indexed for MEDLINE]


Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults.
Blood Adv
Xie Y, Zhou KS, Li LF, Liang AB, Mei H, Zou DH, Li WY, Jin J, Jin ZM, Jing HM, Yang HY, Chen T, Huang HQ, He PC, Cao JN, Xia Z, Gu YE, Zang YB, Zhou ZS, Tian ZZ, Zhu J, Song YQ.
PMID: 41733966 [PubMed - indexed for MEDLINE]


Inclusion, characteristics, and reporting of older patients in recent registration trials for DLBCL.
Blood Adv
Neuendorff NR, Pugh K, Juthani R, Soudant C, Mac Eochagain C, Torka P.
PMID: 41733959 [PubMed - indexed for MEDLINE]


A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.
Blood Adv
Tuscano JM, Othman T, Frankel P, Ruel C, Poh C, Herbert S, Maverakis E, Merleev AA, Luxardi G, Abedi M, Ranganathan R, Modi D, Zain J, Budde EL, Mei M, Rosenberg AS, Hoeg RT, Costello C, Foss FM, William BM, Holland HK, Sharon E, Streicher H, Danilov A, Newman E.
PMID: 41733958 [PubMed - indexed for MEDLINE]


Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma.
Blood Adv
Wang Y, Larson MC, Hwang SR, Villa D, Kugathasan L, Kumar A, Joseph A, Brooks TR, Hill BT, Bond DA, Maddocks KJ, Nizamuddin IA, Kahl BS, Danilov A, Argao C, Ruan J, Ryan CE, Merryman RW, Grover NS, Khan NB, Ouchveridze E, Tun AM, Ayyappan S, Mou E, Pongas GN, Lossos IS, Harris ZI, Munoz JL, Young P, Portell CA, Baidoun F, Alhaj Moustafa M, Reagan PM, Banaszak LG, Pophali PA, Velayati A, Greenwell IB, Gerber D, Jain P, Wang ML, Narkhede MS, Mehta A, Stack AC, Messmer MR, Bhansali RS, Barta SK, Moyo TK, Ghosh N, Kamdar MK, Anna J, Stanisic AV, Karmali R, Maurer MJ, Cerhan JR, Cohen JB, Martin P.
PMID: 41733957 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 166164    Seite 1 von 8309  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1